Loxo Oncology, Inc. LOXO was a big mover last session, as the company saw its shares rise 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.32–$25.54 in the past one-month time frame.
In the last 30 days, the company has seen two downward estimate revisions and the Zacks Consensus Estimate also moved lower. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Loxo Oncology currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked Med-Drugs stock is Acerus Pharmaceuticals Corporation TRLPF, which sports a Zacks Rank #1 (Strong Buy).
Is LOXO going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACERUS PHARMS (TRLPF): Free Stock Analysis Report
LOXO ONCOLOGY (LOXO): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research